Реакция #2146687

ord-9479d13a8d1746ebbe026f8062d709fe

Уравнение реакции

O
water
COc1ccc2nc(-c3ccc(O)cc3)cn2c1
2-(4′-hydroxyphenyl)-6-methoxyimidazo[1,2-a]pyridine
O=C([O-])[O-].[K+].[K+]
potassium carbonate
FCCCBr
1-bromo-3-fluoropropane
COc1ccc2nc(-c3ccc(OCCCF)cc3)cn2c1
2-[4′-(3″-fluoropropoxy)phenyl]-6-methoxyimidazo[1,2-a]pyridine
Выход 63.0%

Растворители

Условия реакции

Подробные условия
See reaction.notes.procedure_details.

Обработка

  1. 1
    Другоеto remove moisture
  2. 2
    workup.DISSOLUTIONwas dissolved in 10 L of N,N-dimethylformamide
  3. 3
    ДругоеAfter the completion of the reaction
  4. 4
    Экстракцияextracted three times with chloroform
  5. 5
    ПромывкаThe combined chloroform layer was washed once with water and once with a saturated sodium chloride solution
  6. 6
    Сушкаdried over anhydrous sodium sulfate
  7. 7
    Фильтрацияfiltered
  8. 8
    Концентрированиеconcentrated
  9. 9
    ДругоеThe resulting crude product was purified by recycle preparative HPLC (HPLC apparatus

Методика

242 mg (corresponding to 1.0 mmol) of 2-(4′-hydroxyphenyl)-6-methoxyimidazo[1,2-a]pyridine that was sufficiently dried to remove moisture was dissolved in 10 L of N,N-dimethylformamide, and 418 mg (corresponding to 3.0 mmol) of potassium carbonate was added thereto. The mixture was supplemented with 140 μL (corresponding to 1.5 mmol) of 1-bromo-3-fluoropropane, and then was stirred at room temperature for 18 hours. After the completion of the reaction, the reaction solution was poured into water and extracted three times with chloroform. The combined chloroform layer was washed once with water and once with a saturated sodium chloride solution, dried over anhydrous sodium sulfate, filtered and concentrated. The resulting crude product was purified by recycle preparative HPLC (HPLC apparatus: LC-908 (under trade name: manufactured by Japan Analytical Industry Co., Ltd.); column: two JAIGEL 2H (under trade name; manufactured by Japan Analytical Industry Co., Ltd.) connected together; mobile phase: chloroform), to obtain 189 mg (corresponding to 0.63 mmol) of 2-[4′-(3″-fluoropropoxy)phenyl]-6-methoxyimidazo[1,2-a]pyridine (hereinafter referred to as Compound 1) (FIG. 2, Step 6).

Источник

DOI: 10.6084/m9.figshare.5104873.v1Патент: US08277777B2uspto-grants-2012_10